COMBINED THERAPY WITH CAPTOPRIL AND POTASSIUM SUPPLEMENTATION - A POTENTIAL FOR HYPERKALEMIA

被引：41
作者：
BURNAKIS, TG
MIODUCH, HJ
机构：
来源：
ARCHIVES OF INTERNAL MEDICINE | 1984年 / 144卷 / 12期
关键词：
D O I：
10.1001/archinte.144.12.2371
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2371 / 2372
页数：2
相关论文
共 11 条
[1]   CLINICAL USE OF AN ORALLY ACTING CONVERTING ENZYME-INHIBITOR - CAPTOPRIL [J].
BRUNNER, HR ;
GAVRAS, H ;
WAEBER, B ;
TEXTOR, SC ;
TURINI, GA ;
WAUTERS, JP .
HYPERTENSION, 1980, 2 (04) :558-566
[2]   ACUTE REGIONAL CIRCULATORY AND RENAL HEMODYNAMIC-EFFECTS OF CONVERTING-ENZYME INHIBITION IN PATIENTS WITH CONGESTIVE HEART-FAILURE [J].
CREAGER, MA ;
HALPERIN, JL ;
BERNARD, DB ;
FAXON, DP ;
MELIDOSSIAN, CD ;
GAVRAS, H ;
RYAN, TJ .
CIRCULATION, 1981, 64 (03) :483-489
[3]   ANGIOTENSIN INHIBITION IN SEVERE HEART-FAILURE - ACUTE CENTRAL AND LIMB HEMODYNAMIC-EFFECTS OF CAPTOPRIL WITH OBSERVATIONS ON SUSTAINED ORAL-THERAPY [J].
FAXON, DP ;
CREAGER, MA ;
SCHICK, EC ;
HALPERIN, JL ;
GAVRAS, H ;
RYAN, TJ .
AMERICAN HEART JOURNAL, 1981, 101 (05) :548-556
[4]   CLINICAL-PHARMACOLOGY AND THERAPEUTIC APPLICATIONS OF THE NEW ORAL ANGIOTENSIN CONVERTING ENZYME-INHIBITOR, CAPTOPRIL [J].
FERGUSON, RK ;
VLASSES, PH .
AMERICAN HEART JOURNAL, 1981, 101 (05) :650-656
[5]  
GROSSMAN A, 1980, LANCET, V1, P712
[6]  
GUYTON AC, 1976, TXB MED PHYSL, P482
[7]  
MASLOWSKI AH, 1981, LANCET, V1, P71
[8]  
PEARSON RE, 1971, HOSP PHARM, V6, P6
[9]   HYPERKALEMIA IN AZOTEMIC PATIENTS DURING ANGIOTENSIN-CONVERTING ENZYME-INHIBITION AND ALDOSTERONE REDUCTION WITH CAPTOPRIL [J].
TEXTOR, SC ;
BRAVO, EL ;
FOUAD, FM ;
TARAZI, RC .
AMERICAN JOURNAL OF MEDICINE, 1982, 73 (05) :719-725
[10]  
VLASSES PH, 1982, PHARMACOTHERAPY, V2, P1
12